Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INCCPIX · Entity 6757 | Director | March 18, 2026 | March 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CUMBERLAND PHARMACEUTICALS INC
Report date March 18, 2026 · Filed March 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 302,338 |
Ending reported balance
After 2026-03-18 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-03-18 · Grant · Acquired 1,800 · Balance 298,338 Row 2 · 2026-03-18 · Grant · Acquired 4,000 · Balance 302,338 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 09, 2023 Filed Oct 17, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $2.06 | $576.80 |
DisclosureSEC source: 0001214659-23-013552 · marketforms-63405.xml · nonDerivative · entry 6 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,793 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 06, 2023 Filed Oct 17, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $1.88 | $526.40 |
DisclosureSEC source: 0001214659-23-013552 · marketforms-63405.xml · nonDerivative · entry 5 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,513 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 05, 2023 Filed Oct 17, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $1.85 | $518.00 |
DisclosureSEC source: 0001214659-23-013552 · marketforms-63405.xml · nonDerivative · entry 4 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,233 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 04, 2023 Filed Oct 17, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 227 | $1.79 | $406.33 |
DisclosureSEC source: 0001214659-23-013552 · marketforms-63405.xml · nonDerivative · entry 3 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 219,953 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 03, 2023 Filed Oct 17, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $1.85 | $518.00 |
DisclosureSEC source: 0001214659-23-013552 · marketforms-63405.xml · nonDerivative · entry 2 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 219,726 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 02, 2023 Filed Oct 17, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $1.89 | $529.20 |
DisclosureSEC source: 0001214659-23-013552 · marketforms-63405.xml · nonDerivative · entry 1 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 219,446 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $1.90 | $532.00 |
DisclosureSEC source: 0001214659-23-013092 · marketforms-62742.xml · nonDerivative · entry 10 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 219,166 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 28, 2023 Filed Oct 3, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $1.96 | $548.80 |
DisclosureSEC source: 0001214659-23-013092 · marketforms-62742.xml · nonDerivative · entry 9 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 218,886 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 27, 2023 Filed Oct 3, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $1.98 | $554.40 |
DisclosureSEC source: 0001214659-23-013092 · marketforms-62742.xml · nonDerivative · entry 8 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 218,606 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 26, 2023 Filed Oct 3, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $2.07 | $579.60 |
DisclosureSEC source: 0001214659-23-013092 · marketforms-62742.xml · nonDerivative · entry 7 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 218,326 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 25, 2023 Filed Oct 3, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $2.24 | $627.20 |
DisclosureSEC source: 0001214659-23-013092 · marketforms-62742.xml · nonDerivative · entry 6 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 218,046 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 22, 2023 Filed Oct 3, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $2.29 | $641.20 |
DisclosureSEC source: 0001214659-23-013092 · marketforms-62742.xml · nonDerivative · entry 5 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 217,766 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 21, 2023 Filed Oct 3, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $2.28 | $638.40 |
DisclosureSEC source: 0001214659-23-013092 · marketforms-62742.xml · nonDerivative · entry 4 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 217,486 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 20, 2023 Filed Oct 3, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $2.14 | $599.20 |
DisclosureSEC source: 0001214659-23-013092 · marketforms-62742.xml · nonDerivative · entry 3 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 217,206 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 19, 2023 Filed Oct 3, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $2.12 | $593.60 |
DisclosureSEC source: 0001214659-23-013092 · marketforms-62742.xml · nonDerivative · entry 2 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 216,926 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 18, 2023 Filed Oct 3, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $2.03 | $568.40 |
DisclosureSEC source: 0001214659-23-013092 · marketforms-62742.xml · nonDerivative · entry 1 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 216,646 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 13:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 72 | $1.82 | $131.04 |
DisclosureSEC source: 0001214659-23-012446 · marketforms-62634.xml · nonDerivative · entry 9 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 216,366 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 14, 2023 Filed Sep 19, 2023 13:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 325 | $1.87 | $607.75 |
DisclosureSEC source: 0001214659-23-012446 · marketforms-62634.xml · nonDerivative · entry 8 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 216,294 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 13, 2023 Filed Sep 19, 2023 13:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 325 | $1.86 | $604.50 |
DisclosureSEC source: 0001214659-23-012446 · marketforms-62634.xml · nonDerivative · entry 7 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 215,969 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 12, 2023 Filed Sep 19, 2023 13:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 325 | $1.79 | $581.75 |
DisclosureSEC source: 0001214659-23-012446 · marketforms-62634.xml · nonDerivative · entry 6 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 215,644 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 11, 2023 Filed Sep 19, 2023 13:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 325 | $1.74 | $565.50 |
DisclosureSEC source: 0001214659-23-012446 · marketforms-62634.xml · nonDerivative · entry 5 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 215,319 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 08, 2023 Filed Sep 19, 2023 13:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 325 | $1.71 | $555.75 |
DisclosureSEC source: 0001214659-23-012446 · marketforms-62634.xml · nonDerivative · entry 4 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 214,994 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 07, 2023 Filed Sep 19, 2023 13:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 325 | $1.71 | $555.75 |
DisclosureSEC source: 0001214659-23-012446 · marketforms-62634.xml · nonDerivative · entry 3 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 214,669 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 06, 2023 Filed Sep 19, 2023 13:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 325 | $1.68 | $546.00 |
DisclosureSEC source: 0001214659-23-012446 · marketforms-62634.xml · nonDerivative · entry 2 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 214,344 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| September 05, 2023 Filed Sep 19, 2023 13:24 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 325 | $1.71 | $555.75 |
DisclosureSEC source: 0001214659-23-012446 · marketforms-62634.xml · nonDerivative · entry 1 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 214,019 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| August 31, 2023 Filed Sep 8, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 325 | $1.70 | $552.50 |
DisclosureSEC source: 0001214659-23-012224 · marketforms-62561.xml · nonDerivative · entry 12 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 213,694 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| August 30, 2023 Filed Sep 8, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 325 | $1.71 | $555.75 |
DisclosureSEC source: 0001214659-23-012224 · marketforms-62561.xml · nonDerivative · entry 11 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 213,369 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| August 29, 2023 Filed Sep 8, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 355 | $1.70 | $603.50 |
DisclosureSEC source: 0001214659-23-012224 · marketforms-62561.xml · nonDerivative · entry 10 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 213,044 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| August 28, 2023 Filed Sep 8, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 325 | $1.74 | $565.50 |
DisclosureSEC source: 0001214659-23-012224 · marketforms-62561.xml · nonDerivative · entry 9 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 212,689 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| August 25, 2023 Filed Sep 8, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 325 | $1.73 | $562.25 |
DisclosureSEC source: 0001214659-23-012224 · marketforms-62561.xml · nonDerivative · entry 8 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 212,364 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| August 24, 2023 Filed Sep 8, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 134 | $1.69 | $226.46 |
DisclosureSEC source: 0001214659-23-012224 · marketforms-62561.xml · nonDerivative · entry 7 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 212,039 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| August 23, 2023 Filed Sep 8, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 325 | $1.73 | $562.25 |
DisclosureSEC source: 0001214659-23-012224 · marketforms-62561.xml · nonDerivative · entry 6 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 211,905 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| August 22, 2023 Filed Sep 8, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 325 | $1.75 | $568.75 |
DisclosureSEC source: 0001214659-23-012224 · marketforms-62561.xml · nonDerivative · entry 5 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 211,580 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| August 21, 2023 Filed Sep 8, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 325 | $1.71 | $555.75 |
DisclosureSEC source: 0001214659-23-012224 · marketforms-62561.xml · nonDerivative · entry 4 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 211,255 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| August 18, 2023 Filed Sep 8, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 325 | $1.73 | $562.25 |
DisclosureSEC source: 0001214659-23-012224 · marketforms-62561.xml · nonDerivative · entry 3 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 210,930 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| August 17, 2023 Filed Sep 8, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 325 | $1.73 | $562.25 |
DisclosureSEC source: 0001214659-23-012224 · marketforms-62561.xml · nonDerivative · entry 2 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 210,605 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| August 16, 2023 Filed Sep 8, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 325 | $1.67 | $542.75 |
DisclosureSEC source: 0001214659-23-012224 · marketforms-62561.xml · nonDerivative · entry 1 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 210,280 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| March 24, 2023 Filed Mar 27, 2023 21:31 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | GrantCommon Stock | 5,000 | $1.97 | $9,850.00 |
DisclosureSEC source: 0001209191-23-021262 · doc4.xml · nonDerivative · entry 1 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 209,955 F1 · shares: Restricted stock award will vest 100% on March 24, 2024. Read SEC document |
| December 21, 2022 Filed Dec 23, 2022 22:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 360 | $2.22 | $799.20 |
DisclosureSEC source: 0001209191-22-062649 · doc4.xml · nonDerivative · entry 15 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,955 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. Read SEC document |
| December 20, 2022 Filed Dec 23, 2022 22:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 370 | $2.31 | $854.70 |
DisclosureSEC source: 0001209191-22-062649 · doc4.xml · nonDerivative · entry 14 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,595 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. Read SEC document |
| December 19, 2022 Filed Dec 23, 2022 22:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 450 | $2.21 | $994.50 |
DisclosureSEC source: 0001209191-22-062649 · doc4.xml · nonDerivative · entry 13 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,225 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. Read SEC document |
| December 16, 2022 Filed Dec 23, 2022 22:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 246 | $2.22 | $546.12 |
DisclosureSEC source: 0001209191-22-062649 · doc4.xml · nonDerivative · entry 12 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,775 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. Read SEC document |
| December 15, 2022 Filed Dec 23, 2022 22:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 144 | $2.24 | $322.56 |
DisclosureSEC source: 0001209191-22-062649 · doc4.xml · nonDerivative · entry 11 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,529 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. Read SEC document |
| December 14, 2022 Filed Dec 23, 2022 22:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 320 | $2.21 | $707.20 |
DisclosureSEC source: 0001209191-22-062649 · doc4.xml · nonDerivative · entry 10 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,385 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. Read SEC document |
| December 13, 2022 Filed Dec 23, 2022 22:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 320 | $2.18 | $697.60 |
DisclosureSEC source: 0001209191-22-062649 · doc4.xml · nonDerivative · entry 9 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,065 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. Read SEC document |
| December 12, 2022 Filed Dec 23, 2022 22:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 105 | $2.14 | $224.70 |
DisclosureSEC source: 0001209191-22-062649 · doc4.xml · nonDerivative · entry 8 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,745 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. Read SEC document |
| December 09, 2022 Filed Dec 23, 2022 22:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 105 | $2.15 | $225.75 |
DisclosureSEC source: 0001209191-22-062649 · doc4.xml · nonDerivative · entry 7 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,640 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. Read SEC document |
| December 08, 2022 Filed Dec 23, 2022 22:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 105 | $2.19 | $229.95 |
DisclosureSEC source: 0001209191-22-062649 · doc4.xml · nonDerivative · entry 6 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,535 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. Read SEC document |
| December 07, 2022 Filed Dec 23, 2022 22:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 105 | $2.18 | $228.90 |
DisclosureSEC source: 0001209191-22-062649 · doc4.xml · nonDerivative · entry 5 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,430 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. Read SEC document |
| December 06, 2022 Filed Dec 23, 2022 22:07 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 105 | $2.19 | $229.95 |
DisclosureSEC source: 0001209191-22-062649 · doc4.xml · nonDerivative · entry 4 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,325 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.